Trial: 202101072

Intermediate-size Expanded Access to ONC201 for Patients with H3 K27M-mutant and/or Midline Gliomas

Phase

N/A

Principal Investigator

Cluster, Andrew

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov